ERCC5 and cancer: We found the XPG gene rs751402 C>T polymorphism associated with increased overall cancer risk (TT vs. CC: odds ratio [OR] = 1.18, 95% confidence interval [CI] =1.01–1.38; CT vs. CC: OR = 1.12, 95% CI = 1.01–1.24; and CT/TT vs. CC: OR = 1.12, 95% CI = 1.002–1.26).